Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis

AYounossi, 2018, Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, 15, 11, 10.1038/nrgastro.2017.109

Marengo, 2016, Progression and natural history of nonalcoholic fatty liver disease in adults, Clin Liver Dis, 20, 313, 10.1016/j.cld.2015.10.010

Schuster, 2018, Triggering and resolution of inflammation in NASH, Nat Rev Gastroenterol Hepatol, 15, 349, 10.1038/s41575-018-0009-6

Mridha, 2017, NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice, J Hepatol, 66, 1037, 10.1016/j.jhep.2017.01.022

Wan, 2016, Role of NLRP3 inflammasome in the progression of NAFLD to NASH, Can J Gastroenterol Hepatol, 2016, 10.1155/2016/6489012

Szabo, 2012, Inflammasomes in liver diseases, J Hepatol, 57, 642, 10.1016/j.jhep.2012.03.035

Wree, 2018, NLRP3 inflammasome-driven liver injury and fibrosis: roles of IL-17 and TNF in mice, Hepatology, 67, 736, 10.1002/hep.29523

Kamari, 2011, Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice, J Hepatol, 55, 1086, 10.1016/j.jhep.2011.01.048

Dixon, 2012, Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis, Lab Invest, 92, 713, 10.1038/labinvest.2012.45

Knorr, 2020, The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis, Semin Liver Dis, 40, 298, 10.1055/s-0040-1708540

Alegre, 2017, Inflammasomes in liver fibrosis, Semin Liver Dis, 37, 119, 10.1055/s-0037-1601350

Wree, 2014, NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice, Hepatology, 59, 898, 10.1002/hep.26592

Inzaugarat, 2019, NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice, Hepatology, 69, 845, 10.1002/hep.30252

Watanabe, 2009, Inflammasome-mediated regulation of hepatic stellate cells, Am J Physiol Gastrointest Liver Physiol, 296, G1248, 10.1152/ajpgi.90223.2008

Gaul, 2021, Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis, J Hepatol, 74, 156, 10.1016/j.jhep.2020.07.041

Benetti, 2013, The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders, Mediators Inflamm, 2013, 10.1155/2013/678627

Soehnlein, 2017, Neutrophils as protagonists and targets in chronic inflammation, Nat Rev Immunol, 17, 248, 10.1038/nri.2017.10

Wu, 2020, NLRP3 inflammasome activation in adipose tissues and its implications on metabolic diseases, Int J Mol Sci, 21, 4184, 10.3390/ijms21114184

Szabo, 2015, Inflammasome activation and function in liver disease, Nat Rev Gastroenterol Hepatol, 12, 387, 10.1038/nrgastro.2015.94

Griffiths, 1995, ATP induces the release of IL-1 from LPS-primed cells in vivo, J Immunol, 154, 2821, 10.4049/jimmunol.154.6.2821

Wree, 2019, Novel drivers of the inflammatory response in liver injury and fibrosis, Semin Liver Dis, 39, 275, 10.1055/s-0039-1685515

Dixon, 2013, Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis, PLoS One, 8, 10.1371/journal.pone.0056100

Petrasek, 2012, IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice, J Clin Invest, 122, 3476, 10.1172/JCI60777

Gieling, 2009, Interleukin-1 participates in the progression from liver injury to fibrosis, Am J Physiol Gastrointest Liver Physiol, 296, G1324, 10.1152/ajpgi.90564.2008

Seki, 2015, Hepatic inflammation and fibrosis: functional links and key pathways, Hepatology, 61, 1066, 10.1002/hep.27332

Csak, 2011, Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, Hepatology, 54, 133, 10.1002/hep.24341

Krenkel, 2017, Liver macrophages in tissue homeostasis and disease, Nat Rev Immunol, 17, 306, 10.1038/nri.2017.11

He, 2017, Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development, Oncotarget, 8, 37657, 10.18632/oncotarget.17489

Pan, 2018, Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release, Cell Immunol, 332, 111, 10.1016/j.cellimm.2018.08.006

Hou, 2020, Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome, Front Immunol, 11, 1149, 10.3389/fimmu.2020.01149

Zheng, 2020, High glucose-aggravated hepatic insulin resistance: role of the NLRP3 inflammasome in Kupffer xells, Obesity (Silver Spring), 28, 1270, 10.1002/oby.22821